Haisco Pharmaceutical Group – World Class Benchmarking
Company: Haisco Pharmaceutical Group Company Limited
Bloomberg ticker: 002653 SZ
Market cap: US$7,253m
Background: Haisco Pharmaceutical Group Company Limited focuses on researching, developing, and producing new drugs, particularly in therapeutic areas like anesthesia, parenteral nutrition, and liver disease. Operating mainly in China, it serves hospitals and pharmacies, with a strong presence in the Chinese market and a growing focus on global innovation.
World Class Benchmarking of Haisco Pharmaceutical Group
- Profitable Growth rank of 5 was up compared to the prior period’s 7th rank
- This is average performance compared to 360 medium Health Care companies worldwide
- Profitability rank of 5 was better than its Growth rank of 7
- Profitability rank of 5 was up compared to the prior period’s 6th rank
- This is average performance compared to peers
- Growth rank of 7 was up compared to the prior period’s 8th rank
- This is below average performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.